Women's responses to information about overdiagnosis in the UK breast cancer screening programme: a qualitative study.
cross_sectional · Level IV
Where this comes from
- Record sourced from PubMed, PMID 23610383.
- Also identified by DOI 10.1136/bmjopen-2013-002703 and PMC identifier 3641428.
- Licence recorded as CC BY-NC.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
To explore the influence of overdiagnosis information on women's decisions about mammography. A qualitative focus group study with purposive sampling and thematic analysis, in which overdiagnosis information was presented. Community and university settings in London. 40 women within the breast screening age range (50-71 years) including attenders and non-attenders were recruited using a recruitment agency as well as convenience sampling methods. Women expressed surprise at the possible extent of overdiagnosis and recognised the information as important, although many struggled to interpret the numerical data. Overdiagnosis was viewed as less-personally relevant than the possibility of 'under diagnosis' (false negatives), and often considered to be an issue for follow-up care decisions rather than screening participation. Women also expressed concern that information on overdiagnosis could deter others from attending screening, although they rarely saw it as a deterrent. After discussing overdiagnosis, few women felt that they would make different decisions about breast screening in the future. Women regard it as important to be informed about overdiagnosis to get a complete picture of the risks and benefits of mammography, but the results of this study indicate that understanding overdiagnosis may not always influence women's attitudes towards participation in breast screening. The results also highlight the challenge of communicating the individual significance of information derived from population-level modelling.